SE404605B - Forfarande for framstellning av vissa angivna 1-(4-cyanfenoxi)-2-hydroxi-3-(2-(5-1h-tetrazolyl)kromon-5-yloxi)propanderivat - Google Patents

Forfarande for framstellning av vissa angivna 1-(4-cyanfenoxi)-2-hydroxi-3-(2-(5-1h-tetrazolyl)kromon-5-yloxi)propanderivat

Info

Publication number
SE404605B
SE404605B SE7316374A SE7316374A SE404605B SE 404605 B SE404605 B SE 404605B SE 7316374 A SE7316374 A SE 7316374A SE 7316374 A SE7316374 A SE 7316374A SE 404605 B SE404605 B SE 404605B
Authority
SE
Sweden
Prior art keywords
propander
cyanphenoxy
chromon
yloxy
tetrazolyl
Prior art date
Application number
SE7316374A
Other languages
English (en)
Inventor
B T Warren
J W Spicer
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Lab filed Critical Miles Lab
Publication of SE404605B publication Critical patent/SE404605B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7316374A 1972-12-05 1973-12-04 Forfarande for framstellning av vissa angivna 1-(4-cyanfenoxi)-2-hydroxi-3-(2-(5-1h-tetrazolyl)kromon-5-yloxi)propanderivat SE404605B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5611772A GB1457254A (en) 1972-12-05 1972-12-05 1-phenoxy-2-hydroxy-3-chromonyloxy-propane derivatives

Publications (1)

Publication Number Publication Date
SE404605B true SE404605B (sv) 1978-10-16

Family

ID=10475767

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316374A SE404605B (sv) 1972-12-05 1973-12-04 Forfarande for framstellning av vissa angivna 1-(4-cyanfenoxi)-2-hydroxi-3-(2-(5-1h-tetrazolyl)kromon-5-yloxi)propanderivat
SE7700663A SE408420B (sv) 1972-12-05 1977-01-21 1-(4-cyanfenoxi)-2-hydroxi-3-(2-amidokromon-5-yloxi)propan till anvendning som mellanprodukt
SE7700664A SE408421B (sv) 1972-12-05 1977-01-21 1-(4-cyanfenoxi)-2-hydroxi-3-(2-cyankromon-5-yloxi)propan-formiat till anvendning som mellanprodukt

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7700663A SE408420B (sv) 1972-12-05 1977-01-21 1-(4-cyanfenoxi)-2-hydroxi-3-(2-amidokromon-5-yloxi)propan till anvendning som mellanprodukt
SE7700664A SE408421B (sv) 1972-12-05 1977-01-21 1-(4-cyanfenoxi)-2-hydroxi-3-(2-cyankromon-5-yloxi)propan-formiat till anvendning som mellanprodukt

Country Status (16)

Country Link
JP (2) JPS533392B2 (sv)
AR (1) AR199426A1 (sv)
AU (1) AU460893B2 (sv)
BE (1) BE808190A (sv)
CA (1) CA1016178A (sv)
CH (1) CH585749A5 (sv)
DE (1) DE2360355C3 (sv)
ES (1) ES421133A1 (sv)
FR (1) FR2208674B1 (sv)
GB (1) GB1457254A (sv)
HU (1) HU166457B (sv)
IL (1) IL43761A (sv)
NL (1) NL179056C (sv)
NO (1) NO138661C (sv)
SE (3) SE404605B (sv)
ZA (1) ZA739197B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5811141U (ja) * 1981-07-14 1983-01-24 本田技研工業株式会社 ブレ−キデイスク
JPS5834235U (ja) * 1981-08-28 1983-03-05 カシオ計算機株式会社 押釦スイツチの可動接片
US5659051A (en) * 1993-07-13 1997-08-19 Sumitomo Chemical Company, Limited Process of producing 2-cyano-4-oxo-4H-benzopyran compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965122A (en) * 1970-12-30 1976-06-22 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof

Also Published As

Publication number Publication date
BE808190A (fr) 1974-03-29
SE408421B (sv) 1979-06-11
DE2360355C3 (de) 1979-06-07
FR2208674A1 (sv) 1974-06-28
AR199426A1 (es) 1974-08-30
NO138661B (no) 1978-07-10
AU6313373A (en) 1975-05-08
NL7316575A (sv) 1974-06-07
FR2208674B1 (sv) 1977-01-28
IL43761A0 (en) 1974-03-14
NL179056B (nl) 1986-02-03
GB1457254A (en) 1976-12-01
JPS533392B2 (sv) 1978-02-06
AU460893B2 (en) 1975-05-08
DE2360355B2 (de) 1978-10-12
ES421133A1 (es) 1976-04-16
IL43761A (en) 1977-10-31
SE7700664L (sv) 1977-01-21
SE7700663L (sv) 1977-01-21
CA1016178A (en) 1977-08-23
JPS5336016B2 (sv) 1978-09-30
JPS50111219A (sv) 1975-09-01
JPS4993367A (sv) 1974-09-05
NL179056C (nl) 1986-07-01
ZA739197B (en) 1974-10-30
CH585749A5 (sv) 1977-03-15
SE408420B (sv) 1979-06-11
DE2360355A1 (de) 1974-06-20
HU166457B (sv) 1975-03-28
NO138661C (no) 1978-10-18

Similar Documents

Publication Publication Date Title
SE417516B (sv) Forfarande for framstellning av racemiska eller optiskt aktiva piperazinderivat
BG15397A3 (bg) Метод за получаване на новипроизводни на n-(триметокси-3,4,5-цинамоил) пиперазин
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE417198B (sv) Analogiforfarande for framstellning av alkanolaminderivat
SE421313B (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
AR203500A1 (es) Procedimiento para preparar nuevos derivados de n-aminoalquil-2-aminoindano
SE409209B (sv) Forfarande for framstellning av n-acetyl-6,7-aziridino-6-desamino-7-deoxi-alfa-tiolinkosaminid-derivat
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE7614320L (sv) Forfarande for framstellning av en ny heterocyklisk forening
SE386166B (sv) Forfarande for framstellning av 2-(2-hydroixialkyl)-pyridiazin(2h)-3-oner
SE404605B (sv) Forfarande for framstellning av vissa angivna 1-(4-cyanfenoxi)-2-hydroxi-3-(2-(5-1h-tetrazolyl)kromon-5-yloxi)propanderivat
FI52735C (sv) Förfarande för framställning av nya pregnadien-21-syraderivat.
SE416953B (sv) Analogiforfarande for framstellning av substituerade fenylamidinokarbamidforeningar
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
AR211379Q (es) Procedimiento para preparar derivados de imidazolidin -4- onas -1, 3- disustituidas